Pantorilla, Alona D.
HRN: 17-04-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2025
MUPIROCIN 2%, 15G (TUBE)
02/01/2025
02/08/2025
TOPICAL
2%
BID
S/P CS
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes